Innoviva (INVA) Other Non-Current Assets (2010 - 2026)
Innoviva (INVA) posted Other Non-Current Assets of $40.5 million for Q1 2026, down 0.53% on a QoQ basis from $40.7 million in Q4 2025, and down 1.8% year-over-year from $41.3 million in Q1 2025.
Innoviva (INVA) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Innoviva's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $40.5 million for Q1 2026.
- Quarterly Other Non-Current Assets fell 1.8% year-over-year to $40.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.5 million (down 1.8% YoY) and the FY2025 annual result came in at $40.7 million, down 1.77% from the prior year.
- Other Non-Current Assets was $40.5 million for Q1 2026 at Innoviva, down from $40.7 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $41.5 million in Q4 2024 and bottomed at $313000.0 in Q1 2022.
- A 5-year average of $14.1 million and a median of $3.6 million in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 38981.82% — and 2025, when it sank 60.71%.
- Innoviva's Other Non-Current Assets stood at $4.3 million in 2022, then slipped by 24.01% to $3.3 million in 2023, then jumped by 1169.57% to $41.5 million in 2024, then declined by 1.77% to $40.7 million in 2025, then fell by 0.53% to $40.5 million in 2026.
- Business Quant data shows INVA's Other Non-Current Assets at $40.5 million in Q1 2026, $40.7 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 40.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.53 Mn |
| Dec 31, 2025 | 40.74 Mn |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 41.18 Mn |
| Mar 31, 2025 | 41.27 Mn |
| Dec 31, 2024 | 41.48 Mn |
| Sep 30, 2024 | 2.80 Mn |
| Jun 30, 2024 | 2.98 Mn |
| Mar 31, 2024 | 3.11 Mn |
| Dec 31, 2023 | 3.27 Mn |
| Sep 30, 2023 | 3.44 Mn |
| Jun 30, 2023 | 3.56 Mn |
| Mar 31, 2023 | 3.89 Mn |
| Dec 31, 2022 | 4.30 Mn |
| Sep 30, 2022 | 4.62 Mn |
| Jun 30, 2022 | 1.16 Mn |
| Mar 31, 2022 | 313,000.00 |
| Dec 31, 2021 | 11,000.00 |
| Sep 30, 2021 | 136,000.00 |
| Jun 30, 2021 | 162,000.00 |